“We Can’t Do It All Alone” Pfizer UK Tells Life Sciences Meeting
Incoming Pfizer UK country manager Ben Osborn outlined the delivery challenges ahead for health-care systems globally at the BioWales Showcase, in London in late February.
You may also be interested in...
Cell and gene therapies, described as the most exciting developments in the life sciences industry, pick up more momentum with every passing month. The spiraling enthusiasm for an activity that will change how health care is delivered was captured by GE, GSK and other key industry players at a leading UK life sciences industry meeting in spring 2017.
£1.3bn ($1.84bn) is the figure quoted most frequently in answer to the question: What is the value of the bioscience industry in Wales? But that figure is a year old, and undersells a dynamic and growing sector. So says MediWales forum manager Gwyn Tudor.
China ambitiously wants to champion domestic medtech manufacturers in the global market. It also needs to ensure foreign manufacturers do not sustainably dominate its home market – while also benefiting from their technical expertise, for the time being at least. Against that backdrop, new Chinese data laws are being eyed by global medtechs with a certain trepidation.